Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) – Research analysts at HC Wainwright lowered their Q2 2023 earnings estimates for shares of Catalyst Pharmaceuticals in a report released on Friday, May 12th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnings per share of $0.27 for the quarter, down from […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Carmen Jeffrey Del sold 40,000 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $16.70, for a total transaction of $668,000.00. Following the sale, the insider now owns 7,541 shares in the company, valued […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) – Stock analysts at HC Wainwright issued their FY2023 earnings per share estimates for Catalyst Pharmaceuticals in a research note issued on Monday, March 20th. HC Wainwright analyst A. Fein expects that the biopharmaceutical company will post earnings of $1.50 per share for the year. HC Wainwright currently […]